I really can’t understand all the hoopla mover E4. It’s definitely not shooting any lights out in Europe. Mithra sp would have been rising. Mayne wouldn’t need to spend $70 million marketing Nextellis in USA this year. It’s definitely no Viagra. $70 M tells me users may need some convincing. I believe this stall in decline of sp and possible stabilising may be due to a perception writedowns have finished more than anything. We will have to wait until November to get any idea regarding Nextellis. 1st quarter figures will be available and remember these 75 E4 specialist trained sales reps have been on the job since March. Plenty of time to get a good indication of future expectations.
MYX Price at posting:
29.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)